Results 111 to 120 of about 41,581 (185)

Atorvastatin pre-exposure in hypercholesterolemia remedies 27HC mediated dendritic cell dysfunctions in triple-negative breast cancer. [PDF]

Mol Ther Oncol
Choudhury PR, Chakravarti M, Bera S, Arora P, Sultana J, Khan MA, Biradar R, Guha A, Dhar S, Ghosh I, Ganguly N, Lasure A, Kashyap P, Das J, Mandal B, Das P, Sarkar A, Datta D, Nandi S, Alam N, Baral R, Banerjee S, Bose A.   +22 more
europepmc   +1 more source

An LC-MS/MS Method for Simultaneous Determination of Almonertinib and Atorvastatin: Evaluating Their Drug-Drug Interactions in Rat. [PDF]

Drug Des Devel Ther
Li H, Wu H, Gao S, Cui L, Xu J, Sun J, Liu Z, Wang Z, Tao X.   +8 more
europepmc   +1 more source

The therapeutic potential of atorvastatin in treatment of <i>G. lamblia</i> infected mice; <i>in silico</i>, parasitological, and histopathological study. [PDF]

Front Vet Sci
Mohamed K, Khodary M, Hamed D, Alhazmi A, Gattan HS, Alruhaili MH, Fadel EF, Elshabrawy HA, El-Kady AM.   +8 more
europepmc   +1 more source

Cost-Utility Analysis of High-Intensity Statins; Atorvastatin 40 and 80 mg versus Rosuvastatin 20 mg from Egyptian Public Payer's Perspective: A Markov Model. [PDF]

Int J Prev Med
Ibrahim A, ElSherbiny D, Alhussaini MA, Masroja A, Anan I.   +4 more
europepmc   +1 more source

Atorvastatin Attenuates Human Cardiac Fibroblast Activation, with Associated Changes in GATA4/MEF2C and Selected Fibrosis-Related microRNAs. [PDF]

Int J Mol Sci
Chomaničová N, Adamičková A, Cervenak Z, Valášková S, Gažová A, Kyselovic J.   +5 more
europepmc   +1 more source

Drug-Drug Interaction of Chiglitazar with Empagliflozin, Atorvastatin, and Valsartan: An Open-Label, Single-Center, Self-Control, 3-Period Study. [PDF]

Drug Des Devel Ther
Sheng L, Li X, Yu J, Yang X, Li H, Xu H.
europepmc   +1 more source

Atorvastatin and almonertinib-induced myopathy in a polypharmacy context: a case report. [PDF]

Front Cardiovasc Med
Zhou J, Yu L, Xu H.
europepmc   +1 more source

The Effect of Liraglutide on the Hypolipidemic, Anti-Inflammatory, and Antioxidant Properties of Atorvastatin Mediated via the Nrf2/HO-1 Signaling Pathway: In Vivo and In Silico Validation. [PDF]

Pharmaceutics
Kamar SA, Magdy YM, Abuamara TMM, Sedky AA, Al-Hazani TMI, Alhelf M, Zayed ES, A Yousef T, Al-Dakhil A, Abou-Krisha MM, Almehmadi SJ, Khedr S.   +11 more
europepmc   +1 more source

[Retracted] Atorvastatin increases lipopolysaccharide-induced expression of tumour necrosis factor-α-induced protein 8-like 2 in RAW264.7 cells. [PDF]

Exp Ther Med
Liu MW, Su MX, Zhang W, Wang L, Qian CY.
europepmc   +1 more source

Effect of Atorvastatin Combined With Herb-Partitioned Moxibustion on PON-1 in Patients With Atherosclerotic Cerebral Infarction: A Randomized Controlled Trial. [PDF]

Brain Behav
An W, Hou X, Wei N, Zhou Y, Xie X, Jin Z, Wang L, Li X, Zhuang W, Chen D.   +9 more
europepmc   +1 more source